Literature DB >> 21544943

Screening of marine algae for potential tyrosinase inhibitor: those inhibitors reduced tyrosinase activity and melanin synthesis in zebrafish.

Seon-Heui Cha1, Seok-Chun Ko, Daekyung Kim, You-Jin Jeon.   

Abstract

In order to find new anti-browning and whitening agents in this study, we investigated 43 indigenous marine algae for tyrosinase inhibitory activity. The extracts from Endarachne binghamiae, Schizymenia dubyi, Ecklonia cava (EC) and Sargassum silquastrum (SS) evidenced potent tyrosinase inhibitory activity similar to that of positive control, kojic acid. Among those marine algae, EC and SS are distributed abundantly on Jeju Island. Therefore, we selected those two species for further studies. Our results evidenced that both species reduced cellular melanin synthesis and tyrosinase activity. On the other hand, we utilized zebrafish as an alternative in vivo model. All the tested samples evidenced excellent inhibitory effects on the pigmentation of zebrafish, most likely due to their potential tyrosinase inhibitory activity. In simultaneous in vivo toxicity tests, no toxicity was observed in either algal species, on the other hand, toxicity was observed in positive controls. These results provided that EC and SS extract could be used as an ingredient for whiting cosmetics and that zebrafish is an alternative in vivo model.
© 2010 Japanese Dermatological Association.

Entities:  

Mesh:

Substances:

Year:  2011        PMID: 21544943     DOI: 10.1111/j.1346-8138.2010.00983.x

Source DB:  PubMed          Journal:  J Dermatol        ISSN: 0385-2407            Impact factor:   4.005


  22 in total

1.  Loss of prdm1a accelerates melanoma onset and progression.

Authors:  Ritsuko Iwanaga; Brittany T Truong; Jessica Y Hsu; Karoline A Lambert; Rajesh Vyas; David Orlicky; Yiqun G Shellman; Aik-Choon Tan; Craig Ceol; Kristin Bruk Artinger
Journal:  Mol Carcinog       Date:  2020-06-20       Impact factor: 4.784

Review 2.  Ten years of algal biofuel and bioproducts: gains and pains.

Authors:  Hui Chen; Tianpei Li; Qiang Wang
Journal:  Planta       Date:  2019-01-02       Impact factor: 4.116

Review 3.  Therapeutic potential and health benefits of Sargassum species.

Authors:  Subhash R Yende; Uday N Harle; Bhupal B Chaugule
Journal:  Pharmacogn Rev       Date:  2014-01

4.  Rhein attenuates inflammation through inhibition of NF-κB and NALP3 inflammasome in vivo and in vitro.

Authors:  Hui Ge; Hao Tang; Yanbing Liang; Jingguo Wu; Qing Yang; Lijin Zeng; Zhongfu Ma
Journal:  Drug Des Devel Ther       Date:  2017-06-06       Impact factor: 4.162

Review 5.  Hypopigmenting Effects of Brown Algae-Derived Phytochemicals: A Review on Molecular Mechanisms.

Authors:  Mohammed Shariful Azam; Jinkyung Choi; Min-Sup Lee; Hyeung-Rak Kim
Journal:  Mar Drugs       Date:  2017-09-24       Impact factor: 5.118

Review 6.  Anti-Pigmentary Natural Compounds and Their Mode of Action.

Authors:  Kyuri Kim; YoonJung Huh; Kyung-Min Lim
Journal:  Int J Mol Sci       Date:  2021-06-08       Impact factor: 5.923

7.  Cosmeceuticals for Hyperpigmentation: What is Available?

Authors:  Rashmi Sarkar; Pooja Arora; K Vijay Garg
Journal:  J Cutan Aesthet Surg       Date:  2013-01

8.  Micrometam C Protects against Oxidative Stress in Inflammation Models in Zebrafish and RAW264.7 Macrophages.

Authors:  Hao Tang; Hui Ge; Zhi-Bin Chen; Xiong-Ming Luo; Feng-Juan Su; Yan-Bing Liang; Zhen-Yu Li; Jing-Guo Wu; Qing Yang; Li-Jin Zeng; Zhong-Fu Ma
Journal:  Mar Drugs       Date:  2015-08-28       Impact factor: 5.118

9.  Ecklonia cava Extract and Dieckol Attenuate Cellular Lipid Peroxidation in Keratinocytes Exposed to PM10.

Authors:  Jeong-Won Lee; Jin Kyung Seok; Yong Chool Boo
Journal:  Evid Based Complement Alternat Med       Date:  2018-03-06       Impact factor: 2.629

10.  Different Levels of Skin Whitening Activity among 3,6-Anhydro-l-galactose, Agarooligosaccharides, and Neoagarooligosaccharides.

Authors:  Ji Hye Kim; Eun Ju Yun; Sora Yu; Kyoung Heon Kim; Nam Joo Kang
Journal:  Mar Drugs       Date:  2017-10-20       Impact factor: 5.118

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.